Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AEMD Aethlon Medical	$1.59 -27.4%	$1.34	$1.08 ▼ $8.44	$4.13M	1.72	7.71 million shs	3.80 million shs
ECIA Encision	$0.21 +0.5%	$0.33	$0.21 ▼ $0.50	$2.51M	0.65	3,441 shs	10,100 shs
UMGP Dalton Industries	$0.02 +4.5%	$0.03	$0.02 ▼ $0.16	$850K	0.13	7,578 shs	1,500 shs
VERO Venus Concept	$2.45 +0.8%	$2.48	$2.10 ▼ $14.50	$3.49M	0.12	30,148 shs	20,382 shs

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AEMD Aethlon Medical	0.00%	+39.47%	+17.78%	-50.05%	-64.79%
ECIA Encision	0.00%	-15.60%	-42.35%	-39.71%	-39.71%
UMGP Dalton Industries	0.00%	-6.88%	-23.33%	-11.54%	-77.00%
VERO Venus Concept	0.00%	+5.60%	-7.55%	+7.46%	-63.13%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AEMD Aethlon Medical	2.6209 of 5 stars	3.0	5.0	0.0	0.0	3.1	0.0	0.6
ECIA Encision	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
UMGP Dalton Industries	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
VERO Venus Concept	0.2948 of 5 stars	0.0	2.0	0.0	0.0	0.0	3.3	0.0

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AEMD Aethlon Medical	2.00	Hold	$56.00	3,422.01% Upside
ECIA Encision	0.00	N/A	N/A	N/A
UMGP Dalton Industries	0.00	N/A	N/A	N/A
VERO Venus Concept	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest UMGP, VERO, ECIA, and AEMD Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
8/14/2025	AEMD Aethlon Medical	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral
7/7/2025	AEMD Aethlon Medical	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral

(Data available from 8/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AEMD Aethlon Medical	N/A	N/A	N/A	N/A	$1.32 per share	N/A
ECIA Encision	$6.55M	0.38	N/A	N/A	$0.14 per share	1.51
UMGP Dalton Industries	$30K	28.21	N/A	N/A	N/A	∞
VERO Venus Concept	$64.83M	0.05	N/A	N/A	$1.95 per share	1.26

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AEMD Aethlon Medical	-$13.39M	-$12.64	N/A	N/A	N/A	N/A	-266.21%	-179.46%	11/12/2025 (Estimated)
ECIA Encision	-$220K	-$0.02	N/A	∞	N/A	-4.34%	-16.99%	-7.45%	11/12/2025 (Estimated)
UMGP Dalton Industries	-$260K	-$0.01	N/A	∞	N/A	N/A	N/A	N/A	N/A
VERO Venus Concept	-$47M	-$50.78	N/A	∞	N/A	-68.77%	-871.77%	-61.92%	N/A

Latest UMGP, VERO, ECIA, and AEMD Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/14/2025	Q2 2025	VERO Venus Concept	-$9.72	-$8.03	+$1.69	-$8.03	$14.01 million	$15.69 million
8/13/2025	Q1 2026	AEMD Aethlon Medical	-$0.68	-$0.85	-$0.17	-$0.85	N/A	N/A
7/10/2025	Q4 2025	ECIA Encision	N/A	-$0.01	N/A	-$0.01	N/A	$1.58 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AEMD Aethlon Medical	N/A	N/A	N/A	N/A	N/A
ECIA Encision	N/A	N/A	N/A	N/A	N/A
UMGP Dalton Industries	N/A	N/A	N/A	N/A	N/A
VERO Venus Concept	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AEMD Aethlon Medical	N/A	2.49	2.49
ECIA Encision	0.10	1.92	0.72
UMGP Dalton Industries	N/A	N/A	N/A
VERO Venus Concept	5.72	1.10	0.79

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AEMD Aethlon Medical	1.99%
ECIA Encision	8.20%
UMGP Dalton Industries	N/A
VERO Venus Concept	87.41%

Insider Ownership

Company	Insider Ownership
AEMD Aethlon Medical	1.20%
ECIA Encision	36.75%
UMGP Dalton Industries	N/A
VERO Venus Concept	28.04%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AEMD Aethlon Medical	10	2.60 million	2.57 million	No Data
ECIA Encision	30	11.88 million	7.51 million	Not Optionable
UMGP Dalton Industries	24	36.80 million	N/A	Not Optionable
VERO Venus Concept	410	1.42 million	1.03 million	Not Optionable

UMGP, VERO, ECIA, and AEMD Headlines

Recent News About These Companies

Analysts Conflicted on These Healthcare Names: Venus Concept (VERO) and TuHURA Biosciences (HURA)

August 22 at 11:14 PM | theglobeandmail.com

Venus Concept Inc. (NASDAQ:VERO) Q2 2025 Earnings Call Transcript

August 16, 2025 | msn.com

Venus Concept Reports Q2 2025 Financial Results

August 15, 2025 | msn.com

Venus Concept Inc. (VERO) Q2 2025 Earnings Call Transcript

August 14, 2025 | seekingalpha.com

Venus Concept Amends Loan Agreements for Financial Relief

August 14, 2025 | theglobeandmail.com

Venus Concept Announces Second Quarter 2025 Financial Results

August 14, 2025 | globenewswire.com

Venus Concept to Release Second Quarter of Fiscal Year 2025 Financial Results on August 14, 2025

July 16, 2025 | globenewswire.com

Venus Concept Inc. to Release Q2 Fiscal 2025 Financial Results on August 14, 2025, with Conference Call Details

July 16, 2025 | quiverquant.comQ

VERO - Venus Concept Inc Financials - Morningstar

July 8, 2025 | morningstar.comM

Venus Concept Executes Debt-to-Equity Exchange Agreement

July 1, 2025 | tipranks.com

Venus Concept Announces $6.5 Million Debt-to-Equity Exchange Transaction

July 1, 2025 | globenewswire.com

Venus Concept Inc News (VERO) - Investing.com

June 26, 2025 | investing.com

Venus Concept Stock Climbs After Stock Offering Closes

June 9, 2025 | marketwatch.com

Venus Concept Inc. Closes Registered Direct Offering and Private Placement Raising Approximately $1.15 Million

June 9, 2025 | quiverquant.comQ

Venus Concept Announces Closing of Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

June 9, 2025 | globenewswire.com

Venus Concept To Sell Hair Business To Meta Healthcare In $20M All-Cash Deal

June 8, 2025 | nasdaq.com

Venus Concept prices $3.45M in direct offering, warrants; shares up over 29%

June 7, 2025 | msn.com

Venus Concept Stock Is Soaring On Friday - Here's Why

June 7, 2025 | aol.comA

Venus Concept Sells Hair Business to Meta Healthcare

June 6, 2025 | tipranks.com

Venus Concept Stock Is Soaring On Friday - Here's Why

June 6, 2025 | benzinga.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

UMGP, VERO, ECIA, and AEMD Company Descriptions

Aethlon Medical NASDAQ:AEMD

$1.59 -0.60 (-27.40%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$1.59 0.00 (0.00%)

As of 08/22/2025 07:59 PM Eastern

Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation. The company was incorporated in 1999 and is based in San Diego, California.

Encision OTCMKTS:ECIA

$0.21 +0.00 (+0.48%)

As of 08/22/2025 03:57 PM Eastern

Encision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. The company provides active electrode monitoring (AEM) surgical instruments and monitors that enhance patient safety and patient outcomes in laparoscopic surgical procedures. Its AEM instruments product line comprises a range of endo-mechanical instruments, including scissors, graspers, and dissectors, as well as fixed-tip electrodes and suction-irrigation electrodes. The company also offers various handles, which are used for advanced laparoscopic procedures that incorporate stiffer shafts and ergonomic features; and AEM EndoShield 2 burn protection systems, as well as markets AEM monitor product line that is used in conjunction with AEM instruments. The company sells its products through a network of direct and independent sales representatives. Encision Inc. was incorporated in 1991 and is based in Boulder, Colorado.

Dalton Industries OTCMKTS:UMGP

$0.02 +0.00 (+4.55%)

As of 08/22/2025 12:16 PM Eastern

Universal Media Group Inc., a media company, produces and distributes media content worldwide. It produces On The Mike, a TV show that primarily include celebrity interviews, music concerts, and other events. The company was formerly known as Dalton Industries Inc. and changed its name to Universal Media Group Inc. in January 2016. Universal Media Group Inc. was founded in 1971 and is based in Boca Raton, Florida.

Venus Concept NASDAQ:VERO

$2.45 +0.02 (+0.82%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$2.44 -0.01 (-0.41%)

As of 08/22/2025 05:49 PM Eastern

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, back, thights, and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time